ES548727A0 - Un procedimiento para producir una linfocina (lk 2) - Google Patents

Un procedimiento para producir una linfocina (lk 2)

Info

Publication number
ES548727A0
ES548727A0 ES548727A ES548727A ES548727A0 ES 548727 A0 ES548727 A0 ES 548727A0 ES 548727 A ES548727 A ES 548727A ES 548727 A ES548727 A ES 548727A ES 548727 A0 ES548727 A0 ES 548727A0
Authority
ES
Spain
Prior art keywords
lymphocine
procedure
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548727A
Other languages
English (en)
Other versions
ES8703161A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59236356A external-priority patent/JPH0811759B2/ja
Priority claimed from JP59236357A external-priority patent/JPS61115099A/ja
Priority claimed from JP60028396A external-priority patent/JPS61115026A/ja
Priority claimed from JP60166754A external-priority patent/JPS61115028A/ja
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of ES8703161A1 publication Critical patent/ES8703161A1/es
Publication of ES548727A0 publication Critical patent/ES548727A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES548727A 1984-11-09 1985-11-08 Un procedimiento para producir una linfocina (lk 2) Expired ES8703161A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP59236356A JPH0811759B2 (ja) 1984-11-09 1984-11-09 新リンホカイン▲ii▼とその製法および用途
JP59236357A JPS61115099A (ja) 1984-11-09 1984-11-09 モノクロ−ナル抗体とその製法
JP60028396A JPS61115026A (ja) 1985-02-18 1985-02-18 新リンホカイン2の製造方法
JP60166754A JPS61115028A (ja) 1985-07-30 1985-07-30 抗腫瘍効果増強剤

Publications (2)

Publication Number Publication Date
ES8703161A1 ES8703161A1 (es) 1987-02-01
ES548727A0 true ES548727A0 (es) 1987-02-01

Family

ID=27458873

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548727A Expired ES8703161A1 (es) 1984-11-09 1985-11-08 Un procedimiento para producir una linfocina (lk 2)
ES556785A Expired ES8801582A1 (es) 1984-11-09 1986-06-25 Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES556785A Expired ES8801582A1 (es) 1984-11-09 1986-06-25 Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).

Country Status (11)

Country Link
US (4) US5019385A (es)
KR (1) KR930004596B1 (es)
AT (1) AT395017B (es)
AU (1) AU603053B2 (es)
CH (1) CH664574A5 (es)
DE (1) DE3539775C2 (es)
ES (2) ES8703161A1 (es)
FR (1) FR2572936B1 (es)
GB (1) GB2168355B (es)
IT (1) IT1184668B (es)
SE (1) SE468853B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
KR101111103B1 (ko) * 2000-02-10 2012-02-13 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US9107879B1 (en) * 2010-04-01 2015-08-18 Vanderbilt University Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164964A (en) * 1967-04-20 1969-09-24 Ceskoslovenska Akademie Ved A Method of Cultivation of Animal Cells, and Apparatus for Carrying Out the Said Method.
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
EP0092163B1 (en) * 1982-04-20 1988-09-28 Sloan-Kettering Institute For Cancer Research Purification of interleukin 2
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
JPS5939832A (ja) * 1982-08-28 1984-03-05 Ajinomoto Co Inc モノクロ−ナル抗体ならびにその製法、使用法
EP0111344A2 (en) * 1982-12-13 1984-06-20 Sloan-Kettering Institute For Cancer Research Anti-interleukin-2 monoclonal antibodies
DE3329449A1 (de) * 1983-08-16 1985-03-07 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Monoklonaler antikoerper, der eine struktur erkennt, die dem human-interleukin-2 (tcgf) und der leichten kette (lambda) von humanimmunglobulin gemeinsam ist, und hybridoma-zell-linien, die diese monoklonalen antikoerper produzieren
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
EP0211899B1 (en) * 1985-02-05 1992-09-23 Cetus Oncology Corporation Purification of native colony stimulating factor-1

Also Published As

Publication number Publication date
GB8527466D0 (en) 1985-12-11
US5019385A (en) 1991-05-28
ES8801582A1 (es) 1988-02-16
IT8548762A0 (it) 1985-11-08
ES556785A0 (es) 1988-02-16
US5002878A (en) 1991-03-26
ATA327685A (de) 1992-01-15
AU603053B2 (en) 1990-11-08
KR860006268A (ko) 1986-09-09
IT1184668B (it) 1987-10-28
FR2572936A1 (fr) 1986-05-16
SE468853B (sv) 1993-03-29
SE8505286L (sv) 1986-05-10
GB2168355B (en) 1989-04-19
ES8703161A1 (es) 1987-02-01
US5003048A (en) 1991-03-26
US5030564A (en) 1991-07-09
CH664574A5 (fr) 1988-03-15
SE8505286D0 (sv) 1985-11-08
DE3539775A1 (de) 1986-11-06
AT395017B (de) 1992-08-25
FR2572936B1 (fr) 1990-07-20
KR930004596B1 (ko) 1993-06-01
GB2168355A (en) 1986-06-18
AU4970885A (en) 1986-05-15
DE3539775C2 (de) 1994-05-26

Similar Documents

Publication Publication Date Title
ES550530A0 (es) Un procedimiento para preparar una composicion detergente
ES551514A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES557321A0 (es) Procedimiento para producir un material fotomodulador
ES547239A0 (es) Un procedimiento para preparar un dentifrico antiplacas
ES532710A0 (es) Un procedimiento para producir 3-(3, 4-dihidroxifenil) serina
ES549713A0 (es) Un procedimiento para preparar 1,4-dihidropiridinas
ES544525A0 (es) Un procedimiento para la produccion de una solucion estabi- lizada de una isotiazolona
ES545386A0 (es) Un procedimiento para preparar un organotitanato
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES536152A0 (es) Un procedimiento para producir l-arginina
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES540732A0 (es) Un procedimiento para la polimeracion de una alfa-monoolefina.
ES542019A0 (es) Procedimiento para producir una n-acilfenilalanina
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES539511A0 (es) Procedimiento para preparar nuevas 8 a-acilaminoergolinas
ES557112A0 (es) Procedimiento para la obtencion de una 9 l 11 l epoxiesteroide
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES548727A0 (es) Un procedimiento para producir una linfocina (lk 2)
ES553481A0 (es) Un procedimiento para producir n-alquil(o alquenil)superior-neoalcanoamidas
ES553811A0 (es) Un procedimiento para preparar una composicion detergente
ES552772A0 (es) Un procedimiento para producir 2,3,4-tri-o-acil-d- y-o l-hexosas
ES535847A0 (es) Un procedimiento para producir un uroquinasa-zimogeno
ES546133A0 (es) Un procedimiento para producir una benzoilurea
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001